Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

'Cashing In' On Biobank Networking: BC Platforms Aims To Globalize Its Finnish Model

Privately-held BC Platforms is one of the networked groups leading the way in clinical genomics data management. Its CEO tells Scrip how the company's foundational start in Finland 21 years ago allowed it to create a critical mass from which it is now expanding globally in the quest to better understand the pathogenic mechanism of diseases.

Digital Health Innovation Research & Development

Future Of Cardio And Mental Health Will Be Defined By Digital Advances

Cardiovascular diseases are responsible for 30% of worldwide deaths, and about 25% of the global population experiences mental illness each year. The negative impact of these conditions on society remain substantial. Development of digital tools to provide support to high-risk groups and patients, healthcare providers, and communities in general, is an area of significant opportunity.

Digital Health Market Intelligence Commercial

What's Keeping Korea From Becoming A Digital Healthcare Power?

While digital healthcare start-ups are increasingly being established in South Korea, strict regulations and a limited market environment are keeping them from adopting innovative ideas and technologies to rapidly catch up with global competitors. A recent report on digital healthcare suggests what issues need to be resolved to improve the situation.

South Korea Digital Health BioPharmaceutical
UsernamePublicRestriction

Register